Dow Jones U.S. Pharmaceuticals Index


D.J. US Pharmaceutical Top 10: Value Investment Strategy

TOP 10 Value VALUEVVV GROWTHVV SAFETYVV COMBINED
1. Phibro Animal (L, US)  Pharmaceuticals
1. Phibro Animal (L, US)   Pharmaceuticals 66 16 27 16
2. Supernus Pharma (M, US)  Pharmaceuticals
2. Supernus Pharma (M, US)   Pharmaceuticals 62 86 59 86
3. Pfizer (XXL, US)  Pharmaceuticals
3. Pfizer (XXL, US)   Pharmaceuticals 56 5 36 12
4. Prestige (L, US)  Pharmaceuticals
4. Prestige (L, US)   Pharmaceuticals 37 43 15 22
5. Assertio Therapeutics (S, US)  Pharmaceuticals
5. Assertio Therapeutics (S, US)   Pharmaceuticals 33 4 1 7

April 2, 2021. Top 10s are published weekly by . ()

D.J. US Pharmaceutical Top 10: Growth Investment Strategy

TOP 10 Growth VALUEVVV GROWTHVV SAFETYVV COMBINED
1. Catalent (L, US)   Pharmaceuticals
1. Catalent (L, US)   Pharmaceuticals 15 96 13 31
2. AbbVie (XXL, US)   Biotechnology
2. AbbVie (XXL, US)   Biotechnology 25 94 5 28
3. Eli Lilly (XXL, US)   Pharmaceuticals
3. Eli Lilly (XXL, US)   Pharmaceuticals 9 88 49 51
4. Supernus Pharma (M, US)   Pharmaceuticals
4. Supernus Pharma (M, US)   Pharmaceuticals 62 86 59 86
5. Nektar (L, US)   Pharmaceuticals
5. Nektar (L, US)   Pharmaceuticals 7 84 27 19
6. Heska (S, US)   Pharmaceuticals
6. Heska (S, US)   Pharmaceuticals 4 79 17 21
7. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals
7. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals 23 74 9 20
8. Amphastar (M, US)   Pharmaceuticals
8. Amphastar (M, US)   Pharmaceuticals 24 54 47 26

April 2, 2021. Top 10s are published weekly by . ()


D.J. US Pharmaceutical Top 10: Safety Investment Strategy

TOP 10 Safety VALUEVVV GROWTHVV SAFETYVV COMBINED
1. Supernus Pharma (M, US)   Pharmaceuticals
1. Supernus Pharma (M, US)   Pharmaceuticals 62 86 59 86
2. Johnson & Johnson (XXL, US)   Pharmaceuticals
2. Johnson & Johnson (XXL, US)   Pharmaceuticals 19 42 52 25
3. Eli Lilly (XXL, US)   Pharmaceuticals
3. Eli Lilly (XXL, US)   Pharmaceuticals 9 88 49 51
4. Amphastar (M, US)   Pharmaceuticals
4. Amphastar (M, US)   Pharmaceuticals 24 54 47 26
5. Merck & Co. (XXL, US)   Pharmaceuticals
5. Merck & Co. (XXL, US)   Pharmaceuticals 25 48 41 25

April 2, 2021. Top 10s are published weekly by . ()


D.J. US Pharmaceutical Top 10: Combined Investment Strategy

TOP 10 Combined VALUEVVV GROWTHVV SAFETYVV COMBINED
1. Supernus Pharma (M, US)   Pharmaceuticals
1. Supernus Pharma (M, US)   Pharmaceuticals 62 86 59 86
2. Eli Lilly (XXL, US)   Pharmaceuticals
2. Eli Lilly (XXL, US)   Pharmaceuticals 9 88 49 51
3. Catalent (L, US)   Pharmaceuticals
3. Catalent (L, US)   Pharmaceuticals 15 96 13 31
4. AbbVie (XXL, US)   Biotechnology
4. AbbVie (XXL, US)   Biotechnology 25 94 5 28
5. Amphastar (M, US)   Pharmaceuticals
5. Amphastar (M, US)   Pharmaceuticals 24 54 47 26

April 2, 2021. Top 10s are published weekly by . ()

This company has a special achievement which is documented on its stock research page.

Top 10 lists may contain fewer than 10 stocks due to Obermatt’s top 10 quality standards.

Top 10 Stocks from the purely finance fact-based Obermatt Method for the investment strategies Value, Growth and Safety in the stock index Dow Jones U.S. Pharmaceuticals Index from April 2, 2021.

Top 10 Stock History D.J. US Pharmaceutical



We invest in our stock tips ourselves and openly publish the returns of our portfolio. That's how much we believe in our stock research. Subscribe to the top 10 stocks for 100 markets conveniently by e-mail.

Get stock news now

Investing made easy